Witnesses Dominic Cummings, Former Chief Adviser to the Prime Minister, Kwasi Kwarteng (Secretary of State at Department for Business, Energy and Industrial Strategy), and Jo Shanmugalingam (Director General for Industrial Strategy, Science and Innovation at Department for Business, Energy and Industrial Strategy)
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Professor David Cebon (Professor of Mechanical Engineering at University of Cambridge), Professor Nilay Shah (Head of the Department of Chemical Engineering at Imperial College London), Michael Liebreich (CEO at Liebreich Associates), Dr Jenifer Baxter (Chief Engineer at Institution of Mechanical Engineers), and Baroness Brown of Cambridge (Chair at Carbon Trust, and Former Vice Chair at Climate Change Committee)
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Anthony Harnden (Deputy Chair, Joint Committee on Vaccination and Immunisation and Professor of Primary Care at University of Oxford), Professor Wendy Barclay (Head of the Department of Infectious Disease at Imperial College London), Dr Philip Dormitzer (Vice President and Chief Scientific Officer of Viral Vaccines at Pfizer), Professor Sarah Gilbert (Professor of Vaccinology at University of Oxford), Madelaine McTernan (Director General at UK Vaccine Taskforce), and Nadhim Zahawi (Minister for COVID Vaccine Deployment at Department for Health and Social Care)
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Dame Angela McLean (Professor of Mathematical Biology at University of Oxford, and Chief Scientific Adviser at Ministry of Defence), Professor Mark Woolhouse OBE (Professor of Infectious Disease Epidemiology at University of Edinburgh), Dr James Rubin (Professor of Psychology & Emerging Health Risks at Kings College London), Professor Sir John Bell (Regius Professor of Medicine at Oxford University), James Hetherington (Chief Data Science Adviser at Joint Biosecurity Centre), and Dr Johanna Hutchinson (Director for Data and Data Science at Joint Biosecurity Centre)
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Baroness Harding of Winscombe (Interim Executive Chair at National Institute for Health Protection), Mark Hewlett (Director of Testing at NHS Test and Trace), and Steve McManus (Director of Tracing at NHS Test and Trace)
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Greg Fell (Director of Public Health at Sheffield City Council), and Dr Richard Harling MBE (Director of Health and Care at Staffordshire County Council)
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Wei Shen Lim (Chair, Covid-19 Immunisation at Joint Committee on Vaccination and Immunisation), Dr Mary Ramsay (Head of Immunisation at Public Health England), Sir Mene Pangalos (Executive Vice President of BioPharmaceuticals Research and Development at AstraZeneca), Tom Keith-Roach (President at AstraZeneca UK), Nadhim Zahawi (Minister for COVID Vaccine Deployment at Department for Health and Social Care), and Antonia Williams (Director (Covid Vaccines) at Department for Health and Social Care)
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Neil Ferguson OBE (Director at MRC Centre for Global Infectious Disease Analysis at Imperial College London), Professor Peter Horby (Chair at New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)), and Professor Wendy Barclay (Head of the Department of Infectious Disease at Imperial College London)
Witnesses Sir Patrick Vallance, Government Chief Scientific Adviser, Professor Chris Whitty, Chief Medical Officer for England, Dr Jenny Harries (Deputy Chief Medical Officer at Department for Health and Social Care), and Dr June Raine (Chief Executive at Medicines and Healthcare products Regulatory Agency (MHRA))
Witnesses Professor Dame Sally Davies, Chief Medical Officer for England (2010-2019), Sir Mark Walport, Government Chief Scientific Adviser (2013-2017), Sir Oliver Letwin, Cabinet Office Minister (2010-2016), and Lord Mark Sedwill, Cabinet Secretary (2018-2020)
Witnesses James O'Rourke, family carer, Steve Scown (Chief Executive at Dimensions UK), Iain Bell (Deputy National Statistician and Director of Population and Public Policy at Office for National Statistics), Professor Kevin Fenton (Public Health and Regional Director for London at Public Health England), Dr Habib Naqvi (Director at NHS Race and Health Observatory, NHS Confederation), and Professor Doctor Ramani Mooneshinghe (National Clinical Director for Critical Care at NHS England and NHS Improvement)
Witnesses Professor Devi Sridhar (Professor of Global Public Health at University of Edinburgh), Alex Thomas (Programme Director at Institute for Government), Matt Hancock (Secretary of State at Department for Health and Social Care), Dr Jenny Harries (Deputy Chief Medical Officer for England at Department for Health and Social Care), and Clara Swinson (Director General for Global and Public Health at Department for Health and Social Care)
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Amy Karam (Global Strategist and Fellow at Canadian Global Affairs Institute), Dr Dritan Kaleshi (Head of Technology (5G) at Digital Catapult), and Oliver Dowden (Secretary of State for Digital, Culture, Media and Sport at Department for Digital, Culture, Media and Sport)
Witnesses Sir John Kingman (Chair at UK Research and Innovation (UKRI)), Professor Dame Ottoline Leyser (Chief Executive at UK Research and Innovation (UKRI)), Amanda Solloway (Minister for Science, Research and Innovation at Department for Business, Energy and Industrial Strategy), and Sarah Hodgetts (Deputy Director for UKRI Sponsorship and Advanced Research Projects Agency at Department for Business, Energy and Industrial Strategy)
Witnesses Professor Dame Anne Johnson (Professor of Infectious Disease Epidemiology at University College London), Professor Sir Chris Ham (Chair at Coventry and Warwickshire Health and Care Partnership, and former Chief Executive at The King's Fund), Professor Dominic Harrison (Director of Public Health at Darwen Borough Council), Baroness Harding of Winscombe (Chair at NHS Test and Trace), Dr Susan Hopkins (Chief Medical Adviser at NHS Test and Trace), Professor Sir John Bell (Regius Professor of Medicine at University of Oxford), Professor Jo Martin (President at Royal College of Pathologists), and Professor Gerard Krause (Head of Department for Epidemiology at Helmholtz Centre for Infection Research, and Director at Institute for Infectious Disease Epidemiology, TWINCORE, Hanover)
Witnesses Professor Peter Horby (Professor of Emerging Infectious Diseases and Global Health at University of Oxford), Professor Andrew Pollard (Trial Chief Investigator at University of Oxford), Professor Robin Shattock (Chair in Mucosal Infection and Immunity at Imperial College London), Professor Wei Shen Lim (Chair, COVID-19 Panel at Joint Committee on Vaccination and Immunisation), and Kate Bingham (Chair at UK Vaccine Taskforce)
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Lord Livingston of Parkhead (Chair at Telecoms Diversification Taskforce), Scott Bailey (Deputy Director of the Diversification Unit at Department for Digital, Culture, Media and Sport), Tareq Amin (Chief Technology Officer at Rakuten Mobile), Dr Tobias Feakin (Ambassador for Cyber Affairs and Critical Technology at Australian Government), Dr Ian Levy (Technical Director at National Cyber Security Centre), and Dr Yih-Choung Teh (Group Director for Strategy and Research at Ofcom)